Reside Either in Retirement Home or Long-term Care Units
Conditions
Keywords
Retirement Home (EHPAD), Long-term Care Units (USLD), Coronavirus, Vaccination
Brief summary
The main objective of this non-interventional, multi-center study is to compare the incidence of serious health events (death, unscheduled hospitalizations) in subjects vaccinated against Coronavirus with that of unvaccinated subjects, in Retirement Home (EHPAD) and Long-term Care Units (USLD) in Ile-De-France during the same observation period 12-months minimun and up to18 months according vaccinal schedule. The primary outcome will be the incidence of serious health events (death and unscheduled hospitalizations) in subjects vaccinated against Coronavirus compared to that of unvaccinated subjects.
Detailed description
This multicenter study is a parallel cohort to the first phase of the vaccination campaign against Coronavirus, in particular for elderly subjects in institutions. All subjects who will not oppose the study will be included and this date will correspond to Day 0. D0 will correspond to the date of the first vaccine injection for subjects in the vaccine group. The subjects included will be followed up on D21, D90, M6, 12 months (M12) and up to 18 months in the case of 3rd vaccinal injection The following data will be collected at inclusion and during follow-up: * Age, weight, sex, level of autonomy * Chronic diseases * Any hospitalizations * Possible symptoms after vaccination for subjects who choose to be vaccinated * The fate of the subjects and the evaluation of the immune response * Hospitalizations and vital status of subjects Serology data prescribed by doctors as part of routine care will also be collected.
Interventions
None listed
Sponsors
Gérond'if
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
Yes
Inclusion criteria
* Subject in Retirement Home (EHPAD) or Long-term Care Units (USLD) during the anti-Coronavivus vaccination period. * Subject not opposing the study or whose legal representative does not oppose the study.
Exclusion criteria
* Subject not affiliated to a social security scheme.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of the incidence of serious events in subjects vaccinated against CORONAVIRUS compared to those not vaccinated using their number, percentage and 95% confidence interval and methods of survival analysis Kaplan Meier and Cox model | 12 months or 18 months in the case of the 3rd vaccinal injection |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of the incidence of geriatric syndromes using their number, percentage and 95% confidence interval and survival analysis methods: Kaplan Meier and Cox model | 3 months |
| Evaluating the Incidence of Organ Decompensations according Their Number, Percentage, and 95% Confidence Interval and Survival Analysis Methods: Kaplan Meier and Cox Model | 6 months |
| Assessment of the incidence of serious and non-serious side effects using their number, percentage and 95% confidence interval and survival analysis methods: Kaplan Meier and Cox model. Kaplan Meier and Cox model | 3 months |
| Comparison of the incidence of symptomatic and severe coronavirus in vaccinated and unvaccinated subjects using their number, percentage and 95% confidence interval and survival analysis methods: Kaplan Meier and Cox Model. Kaplan Meier and Cox model | 3 months |
Other
| Measure | Time frame |
|---|---|
| Carrying out adjustment analyzes by multivariate logistic regressions on confounding factors | 3 months |
| Performing propensity score analyzes to balance the vaccinated and unvaccinated groups | 3 months |
Countries
France
Contacts
Primary ContactIsabelle Dufour
Backup ContactAdrien Besseiche
Outcome results
None listed